1801151-15-4
Chemical Structure
BMT-108908
- CAS No.: 1801151-15-4
- Formula:C22H25FN2O2
- Molecular Weight:368.44
IUPAC Name: (R)-1-(4-fluorobenzyl)-3-(4-(4-hydroxyphenyl)piperidin-1-yl)pyrrolidin-2-one
InChIKey: KOQYBHVHTCKDIZ-OAQYLSRUSA-N
SMILES: O=C1[C@H](N2CCC(C3=CC=C(C=C3)O)CC2)CCN1CC4=CC=C(C=C4)F
Biological Activity: BMT-108908 is a negative allosteric modulator with selective activity on the NR2B subtype of the NMDA receptor. BMT-108908 has been shown to damage cognition in research, affecting cognitive functions in multiple areas. BMT-108908 failed to show a significant impact on the γ wave power of the EEG in the experiment, but it had a significant inhibitory and enhancement effect on the β wave and δ wave power[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BMT-108908 | BMT-108908 is a negative allosteric modulator with selective activity on the NR2B subtype of the NMDA receptor. BMT-108908 has been shown to damage cognition in research, affecting cognitive functions in multiple areas. BMT-108908 failed to show a significant impact on the γ wave power of the EEG in the experiment, but it had a significant inhibitory and enhancement effect on the β wave and δ wave power. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
